IMPACT OF HIGH-DOSE PRETREATMENT OF ROSUVASTATIN IN PATIENTS WITH ACUTE CORONARY SYNDROME FOLLOWING OFF-PUMP CORONARY ARTERY BYPASS: RESULTS FROM THE HIROP-ACS (HIGH-DOSE PRETREATMENT OF ROSUVASTATIN DURING OFF-PUMP CORONARY BYPASS IN ACUTE CORONARY SYNDROME) STUDY: